K-pop

"The King of Pop" Cho Yong-pil Returns to the Stage… Solo Concert at K-Sport Dome in November

Concert to Be Held for the First Time in 10 Months… Ticket Sales Begin on the 18th

KIM HYUNSIK
2026-09-16 10:04:52
[Edaily Starin KIM HYUNSIK Reporter] "King of Song" Cho Yong-pil is set to reunite with his fans through a concert.
(Photo: YPC)
According to his agency, YPC, on the 16th, Cho Yong-pil will hold the “2026 Cho Yong-pil & The Great Birth Concert” for three days from November 27 to 29 at the KSPO DOME in Olympic Park, Songpa-gu, Seoul.
Since beginning his music career in 1968, Cho Yong-pil has produced numerous hit songs—including “Come Back to Busan Harbor,” “The Woman Outside the Window,” “Short Hair,” “The Leopard of Kilimanjaro,” “Bounce,” “Song of the Wind,” and “Dream”—earning him the title of “King of Song.”
This will be his first solo concert in 10 months, following his performance at the same venue last January. Tickets will be available for purchase starting at 2:00 p.m. on the 18th via Yes24 Ticket.
His agency stated, “This concert will be an opportunity to experience Cho Yong-pil’s musical legacy—a legacy built over many years with countless masterpieces—all in one place,” adding, “Cho Yong-pil will collaborate with the band ‘The Great Birth’ to deliver a highly polished performance.”

Economy

Corporation

IT·Science

Economy

Xcell Therapeutics Inc. Aims to Raise 8 Billion Won by Year-End… Will It Avoid the Risk of Negative Equity?

#Xcell Therapeutics Inc. is pursuing a third-party private placement worth 7 to 8 billion won to avoid the risk of negative equity by year-end. This comes after the company raised funds through a 9.5 …
2026-11-09 08:02:02

Corporation

Kim Dong-seon Launches Another Tender Offer for Hanwha M&S… Invests an Additional 27 billion won

Kim Dong-seon, President of Future Strategy at #Hanwha Machinery & Service Holdings (Hanwha M&S), is launching an additional tender offer for Hanwha M&S shares, investing approximately 27 billion won.…
2026-11-09 09:13:59

IT·Science

NIBEC CO., LTD. Pursues Global Technology Transfer Led by New Drugs for Obesity and Cardiovascular Diseases

NIBEC CO., LTD.(138610)is seeking to expand its collaboration with global pharmaceutical companies. The company plans to discuss partnerships focused on obesity treatments that simultaneously target b…
2026-11-09 10:49:02